Home > News > Nanotechnology and Venture Capital
March 4th, 2004
Nanotechnology and Venture Capital
By Pearl Chin - Managing General Partner, Seraphima Ventures. To simplify a potentially long article, nanotechnology and venture capital at this stage can be characterized by this often made statement by some venture capitalists about investing in nanotechnology: "It's too early to invest in nanotechnology."
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014